<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
    xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://wiseek.ai/ticker/bctx/news/briacell-therapeutics-prices-4-7m-offering-at-discount-shares-diluted-e90e2b74a6b5fa5915bdb2a89a72c425b5c11232104e7da4c93d5b4a5b08ff66/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T23:59:00.000Z</news:publication_date>
      <news:title>BriaCell Therapeutics Prices $4.7M Offering at Discount, Shares Diluted</news:title>
      <news:keywords>financial news, stock market, SEC filings, BCTX</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/tsla/news/tesla-french-registrations-skyrocket-655-in-may-crushing-market-growth-82a9a1540960897135985a22071f457a1eb74bbbf935e8622651bbb1ee03ccdf/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T23:39:30.000Z</news:publication_date>
      <news:title>Tesla French Registrations Skyrocket 655% in May, Crushing Market Growth</news:title>
      <news:keywords>financial news, stock market, SEC filings, TSLA</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/tsla/news/tesla-secures-graphite-supply-withdraws-termination-notice-on-syrah-deal-35aaf77d1b15d0054b6509ae2b5adc5f638a0e7ac57cf2b16026ed002256911a/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T23:12:28.000Z</news:publication_date>
      <news:title>Tesla secures graphite supply, withdraws termination notice on Syrah deal</news:title>
      <news:keywords>financial news, stock market, SEC filings, TSLA</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/cang/news/cango-reports-254-4m-operating-loss-in-q1-dwarfing-revenue-amid-delisting-threat-143a97140b1d02dcfb898b3aefeac34738714fe887ef7dd7cdd8a7a222a8daec/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T22:03:48.000Z</news:publication_date>
      <news:title>Cango Reports $254.4M Operating Loss in Q1, Dwarfing Revenue Amid Delisting Threat</news:title>
      <news:keywords>financial news, stock market, SEC filings, CANG</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/brka/news/8-5-billion-homebuilder-takeover-marks-ceo-abel-s-first-major-deal-at-berkshire-hathaway-828bd99c9546e009f84005ec679885e60bdae4c09db182e9081211f18b95aed6/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T21:57:00.000Z</news:publication_date>
      <news:title>$8.5 Billion Homebuilder Takeover Marks CEO Abel&apos;s First Major Deal at Berkshire Hathaway</news:title>
      <news:keywords>financial news, stock market, SEC filings, BRKA</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/tmhc/news/homebuilder-taylor-morrison-to-be-acquired-by-berkshire-hathaway-for-8-5-billion-a8e0c5b5d3bf4aecae7012e7efa7532b97b828e69457e77a043352c6a60d64c7/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T20:34:14.000Z</news:publication_date>
      <news:title>Homebuilder Taylor Morrison to be Acquired by Berkshire Hathaway for $8.5 Billion</news:title>
      <news:keywords>financial news, stock market, SEC filings, TMHC</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/tmhc/news/berkshire-hathaway-to-acquire-taylor-morrison-for-8-5-billion-d88b406dcd8c6e425623c4d0a9fbfcb340cac89d3a15bf1ea24590c73e7fb4ae/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T20:30:00.000Z</news:publication_date>
      <news:title>Berkshire Hathaway to Acquire Taylor Morrison for $8.5 Billion</news:title>
      <news:keywords>financial news, stock market, SEC filings, TMHC</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/mstr/news/saylor-teases-imminent-bitcoin-purchase-mstr-rallies-retail-for-key-proxy-vote-0dfe0aea23cf7a7998dbf5466c3f42f72417f55956bf9c338ed4071ac02208b8/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T20:00:12.000Z</news:publication_date>
      <news:title>Saylor Teases Imminent Bitcoin Purchase; MSTR Rallies Retail for Key Proxy Vote</news:title>
      <news:keywords>financial news, stock market, SEC filings, MSTR</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/ih/news/ihuman-acquires-ai-powered-learning-platforms-all-knowledge-perfect-lingo-for-13m-names-new-co-ceo-890e5cbc158194b6738e8b0cba79d30b11992d981937efa966943bfcdf6c62fa/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T16:03:00.000Z</news:publication_date>
      <news:title>iHuman Acquires AI-Powered Learning Platforms All Knowledge &amp; Perfect Lingo for $13M+, Names New Co-CEO</news:title>
      <news:keywords>financial news, stock market, SEC filings, IH</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/jnj/news/j-j-s-erleada-cuts-prostate-cancer-spread-death-risk-by-20-in-late-stage-trial-b667fec987fe2526a43071d5b57875e1e50aa38af2625fdfa0a6b2a1c7279ad0/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T12:00:00.000Z</news:publication_date>
      <news:title>J&amp;J&apos;s Erleada Cuts Prostate Cancer Spread &amp; Death Risk by 20% in Late-Stage Trial</news:title>
      <news:keywords>financial news, stock market, SEC filings, JNJ</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/rvmd/news/revolution-medicines-pancreatic-cancer-drug-doubles-survival-fda-plans-speedy-review-1786d6e2e0406a83d0f90f0c3b7f54e60db14f6db1c547bb7dbdf49b15ce54ff/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T12:00:00.000Z</news:publication_date>
      <news:title>Revolution Medicines&apos; Pancreatic Cancer Drug Doubles Survival, FDA Plans Speedy Review</news:title>
      <news:keywords>financial news, stock market, SEC filings, RVMD</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/elek/news/volkswagen-to-review-elektros-multi-port-ev-charging-patent-c3630733b41eaf8ccfba675a6d8db0a1ee35b7f2b509c15101941220efe46354/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T02:00:00.000Z</news:publication_date>
      <news:title>Volkswagen to Review Elektros&apos; Multi-Port EV Charging Patent</news:title>
      <news:keywords>financial news, stock market, SEC filings, ELEK</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/bntx/news/biontech-bms-pumitamig-shows-encouraging-phase-2-efficacy-in-nsclc-high-response-rates-across-pd-l1-levels-f5b50720a0a88f792ec79e68d4c80d26d7806757af1fe7e4f1eb9dad36ec75e2/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T18:15:00.000Z</news:publication_date>
      <news:title>BioNTech &amp; BMS Pumitamig Shows Encouraging Phase 2 Efficacy in NSCLC, High Response Rates Across PD-L1 Levels</news:title>
      <news:keywords>financial news, stock market, SEC filings, BNTX</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/exel/news/cabometyx-shows-strong-efficacy-reducing-progression-death-risk-by-up-to-74-in-neuroendocrine-tumors-b4882ed4f351b4edd178c44b217bf60ce876de1af396a600ca6ea034a5f73fca/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T14:03:38.000Z</news:publication_date>
      <news:title>Cabometyx Shows Strong Efficacy, Reducing Progression/Death Risk by Up to 74% in Neuroendocrine Tumors</news:title>
      <news:keywords>financial news, stock market, SEC filings, EXEL</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/goss/news/lawsuit-deadline-nears-for-gossamer-bio-investors-alleging-concealed-placebo-risk-in-failed-drug-trial-a13f07cd026e24d78844bf041e0e4be1755a6542443b88899d6f3f7f9c5cfda3/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T13:57:00.000Z</news:publication_date>
      <news:title>Lawsuit Deadline Nears for Gossamer Bio Investors Alleging Concealed Placebo Risk in Failed Drug Trial</news:title>
      <news:keywords>financial news, stock market, SEC filings, GOSS</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/gral/news/galleri-trial-shows-26-reduction-in-stage-iv-cancer-diagnoses-misses-primary-endpoint-af40be46f220c05de713cc86f4378dddb3fa201af7a773c9fa4e35f8d7c92f72/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T12:14:19.000Z</news:publication_date>
      <news:title>Galleri Trial Shows 26% Reduction in Stage IV Cancer Diagnoses, Misses Primary Endpoint</news:title>
      <news:keywords>financial news, stock market, SEC filings, GRAL</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/imnm/news/immunome-s-varegacestat-shows-statistically-significant-efficacy-across-all-key-endpoints-f9381536d5d748b625637a4e28398ce9ffce4b00984595cab3c1da3daf4f5a4a/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T12:12:38.000Z</news:publication_date>
      <news:title>Immunome&apos;s Varegacestat Shows Statistically Significant Efficacy Across All Key Endpoints</news:title>
      <news:keywords>financial news, stock market, SEC filings, IMNM</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/pfe/news/pfizer-s-talzenna-xtandi-combo-shows-over-50-survival-improvement-in-prostate-cancer-trial-b5f2ee3beb7086b550329801f072bc40c72062e5111d3123b280c2b3f3ce89d4/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T12:06:26.000Z</news:publication_date>
      <news:title>Pfizer&apos;s Talzenna/Xtandi Combo Shows Over 50% Survival Improvement in Prostate Cancer Trial</news:title>
      <news:keywords>financial news, stock market, SEC filings, PFE</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/repl/news/replimune-s-rp1-shows-durable-3-year-survival-in-advanced-melanoma-09a7ade7e3c8ee85820c166198851699ed971c40d5cd854c54f289dd57799411/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T12:00:00.000Z</news:publication_date>
      <news:title>Replimune&apos;s RP1 Shows Durable 3-Year Survival in Advanced Melanoma</news:title>
      <news:keywords>financial news, stock market, SEC filings, REPL</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://wiseek.ai/ticker/incy/news/incyte-s-monjuvi-combo-reduces-blood-cancer-progression-by-25-targets-expanded-first-line-use-despite-high-side-effects-dbefc0fec9cfbed1d2d98930d96543bc747609ad8956c3d77e33ab27c0215a2b/</loc>
    <news:news>
      <news:publication>
        <news:name>Wiseek.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T12:00:00.000Z</news:publication_date>
      <news:title>Incyte&apos;s Monjuvi Combo Reduces Blood Cancer Progression by 25%, Targets Expanded First-Line Use Despite High Side Effects</news:title>
      <news:keywords>financial news, stock market, SEC filings, INCY</news:keywords>
    </news:news>
  </url>
</urlset>